Stefan Cross's Net Worth
$163 Thousand
Who is Stefan Cross?
Stefan Cross does not have any significant net worth to report based on the numbers we have. This is based on reported shares in HedgePath Pharmaceuticals, Inc..
SEC CIK
Stefan Cross's CIK is 0001611506
Past Insider Trading and Trends
2017 was Stefan Cross's most active year for acquiring shares with 2 total transactions. Stefan Cross's most active month to acquire stocks was the month of February. 2017 was Stefan Cross's most active year for disposing of shares, totalling 3 transactions. Stefan Cross's most active month to dispose stocks was the month of February. 2017 saw Stefan Cross paying a total of $0.00 for 600,000 shares, this is the most they've acquired in one year. In 2017 Stefan Cross cashed out on 1,200,000 shares for a total of $162,660.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HedgePath Pharmaceuticals, Inc. (INTI) Snapshot price: $0.08
InvestorStefan Cross used to own units in Common Stock but no longer holds any shares there. In the year 2014 Stefan Cross acquired a total of 600,000 shares in HedgePath Pharmaceuticals, Inc., Stefan also disposed a total of 600,000 shares of HedgePath Pharmaceuticals, Inc. equalling to $162,660.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -600.00K |
$0.27 | -$162,660.00 |
0
|
Dec 19
| |||
Form 4
|
∞
| 600K |
—
|
—
| 600K |
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||